Close

Paratek Pharmaceuticals (PRTK) Provides Pipeline Update

January 3, 2018 7:07 AM EST Send to a Friend
Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login